Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Off-label reports of new biologics: exciting new therapy or dubious research? Examples from recombinant activated factor VII.

    Shalmi M, Aurup P.

    J Intensive Care Med. 2006 Jul-Aug;21(4):247-8. No abstract available. PMID: 16855060 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

    Wachtell K, Hornestam B, Lehto M, Slotwiner DJ, Gerdts E, Olsen MH, Aurup P, Dahlöf B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Rokkedal J, Devereux RB.

    J Am Coll Cardiol. 2005 Mar 1;45(5):705-11.PMID: 15734614 [PubMed - indexed for MEDLINE]Related articles

    3.

    Prognostic significance of left ventricular mass change during treatment of hypertension.

    Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B.

    JAMA. 2004 Nov 17;292(19):2350-6.PMID: 15547162 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B; LIFE Study Investigators.

    JAMA. 2004 Nov 17;292(19):2343-9.PMID: 15547161 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.

    Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P.

    Ann Intern Med. 2003 Dec 2;139(11):901-6.PMID: 14644892 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.

    Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Helle Berg S, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE Study Group.

    Ann Intern Med. 2003 Aug 5;139(3):169-77.PMID: 12899584 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.

    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B; Losartan Intervention for Endpoint reduction in hypertension Study Investigations.

    Circulation. 2003 Aug 12;108(6):684-90. Epub 2003 Jul 28.PMID: 12885747 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.

    Kjeldsen SE, Dahlöf B, Devereux RB, Julius S, Aurup P, Edelman J, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE (Losartan Intervention for Endpoint Reduction) Study Group.

    JAMA. 2002 Sep 25;288(12):1491-8.PMID: 12243636 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

    Lindholm LH, Ibsen H, Borch-Johnsen K, Olsen MH, Wachtell K, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman JM, Snapinn S; LIFE study group.

    J Hypertens. 2002 Sep;20(9):1879-86.PMID: 12195132 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.

    Dahlof B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, Aurup P, Smith RD, Johansson M; REGAAL Study Investigators.

    J Hypertens. 2002 Sep;20(9):1855-64. Erratum in: J Hypertens. 2002 Nov;20(11):2315. PMID: 12195129 [PubMed - indexed for MEDLINE]Related articles

    11.

    Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristiansson K, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wedel H, Aurup P, Edelman J, Snapinn S; LIFE Study Group.

    Lancet. 2002 Mar 23;359(9311):1004-10.PMID: 11937179 [PubMed - indexed for MEDLINE]Related articles

    12.
    13.

    Efficacy and safety of losartan/hydrochlorothiazide in patients with severe hypertension.

    Oparil S, Aurup P, Snavely D, Goldberg A.

    Am J Cardiol. 2001 Mar 15;87(6):721-6.PMID: 11249890 [PubMed - indexed for MEDLINE]Related articles

    14.

    Losartan and renal transplantation.

    Aurup P, Smith RD.

    Lancet. 1998 Mar 28;351(9107):990. No abstract available. PMID: 9734972 [PubMed - indexed for MEDLINE]Related articles

    15.

    Tackling ACE-inhibitor cough.

    Aurup P.

    Lancet. 1997 Dec 20-27;350(9094):1854-5. No abstract available. PMID: 9428279 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effect on collagen metabolism of thrombolytic therapy with tissue-plasminogen activator. A randomized, placebo-controlled study.

    Høst NB, Stoltenberg MB, Jensen LT, Larsen OG, Aurup P.

    Eur J Clin Invest. 1995 Jan;25(1):15-8.PMID: 7705381 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of oral magnesium supplementation on cardiac events among survivors of an acute myocardial infarction.

    Galløe AM, Rasmussen HS, Jørgensen LN, Aurup P, Balsløv S, Cintin C, Graudal N, McNair P.

    BMJ. 1993 Sep 4;307(6904):585-7.PMID: 8401013 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The prevalence of myocardial ischemia six months after thrombolytic treatment of acute coronary episodes. A subset of a placebo controlled, randomised trial, the ASSET Study.

    Vaage-Nilsen M, Aurup P, Høegholm A, Eidemark I, Rasmussen V, Jensen G.

    Int J Cardiol. 1993 Jun;39(3):187-93.PMID: 8101512 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Serotonin and cardiovascular control]

    Aurup P, Højberg S.

    Ugeskr Laeger. 1990 Sep 24;152(39):2840-3. Review. Danish. PMID: 2219514 [PubMed - indexed for MEDLINE]Related articles

    20.

    Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study.

    Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, Lawaetz H.

    Arch Intern Med. 1989 May;149(5):1050-3.PMID: 2719498 [PubMed - indexed for MEDLINE]Related articles

    21.

    Myocardial contractility and performance capacity after magnesium infusions in young healthy persons: a double-blind, placebo-controlled, cross-over study.

    Rasmussen HS, Videbaek R, Melchior T, Aurup P, Cintin C, Pedersen NT.

    Clin Cardiol. 1988 Aug;11(8):541-5.PMID: 3168339 [PubMed - indexed for MEDLINE]Related articles

    22.
    23.

    [Duration of symptoms prior to hospitalization and mode of admission in acute myocardial infarction]

    Aurup P, Cintin C, Nielsen JD, Jensen G.

    Ugeskr Laeger. 1988 Jul 25;150(30):1836-8. Danish. No abstract available. PMID: 3413853 [PubMed - indexed for MEDLINE]Related articles

    24.

    [Magnesium and cardiovascular disease. II. The significance of magnesium deficiency for cardiovascular disease]

    Rasmussen HS, Aurup P, McNair P.

    Ugeskr Laeger. 1988 Feb 22;150(8):477-80. Review. Danish. No abstract available. PMID: 3281350 [PubMed - indexed for MEDLINE]Related articles

    25.

    [Magnesium and cardiovascular disease. I. Do patients with ischemic heart disease suffer from magnesium deficiency?]

    Rasmussen HS, Aurup P, McNair P.

    Ugeskr Laeger. 1988 Feb 22;150(8):475-7. Review. Danish. No abstract available. PMID: 3281349 [PubMed - indexed for MEDLINE]Related articles

    26.

    Magnesium deficiency in patients with ischemic heart disease with and without acute myocardial infarction uncovered by an intravenous loading test.

    Rasmussen HS, McNair P, Gøransson L, Balsløv S, Larsen OG, Aurup P.

    Arch Intern Med. 1988 Feb;148(2):329-32.PMID: 3341837 [PubMed - indexed for MEDLINE]Related articles

    27.

    Magnesium and acute myocardial infarction. Transient hypomagnesemia not induced by renal magnesium loss in patients with acute myocardial infarction.

    Rasmussen HS, Aurup P, Hojberg S, Jensen EK, McNair P.

    Arch Intern Med. 1986 May;146(5):872-4.PMID: 3963976 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...